| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Biophysical Journal 63: 111-128 (1992)
© 1992 the Biophysical Society
Department of Anatomy, University of Pennsylvania School of Medicine, Philadelphia 19104-6058.
ABSTRACT
Although much is known about fibrin polymerization, because it is complex, the effects of various modifications are not intuitively obvious and many experimental observations remain unexplained. A kinetic model presented here that is based on information about mechanisms of assembly accounts for most experimental observations and allows hypotheses about the effects of various factors to be tested. Differential equations describing the kinetics of polymerization were written and then solved numerically. The results have been related to turbidity profiles and electron microscope observations. The concentrations of intermediates in fibrin polymerization, and fiber diameters, fiber and protofibril lengths have been calculated from these models. The simplest model considered has three steps; fibrinopeptide A cleavage, protofibril formation, and lateral aggregation of protofibrils to form fibers. The average number of protofibrils per fiber, which is directly related to turbidity, can be calculated and plotted as a function of time. The lag period observed in turbidity profiles cannot be accurately simulated by such a model, but can be simulated by modifying the model such that oligomers must reach a minimum length before they aggregate. Many observations, reported here and elsewhere, can be accounted for by this model; the basic model may be modified to account for other experimental observations. Modeling predicts effects of changes in the rate of fibrinopeptide cleavage consistent with electron microscope and turbidity observations. Changes only in the rate constants for initiation of fiber growth or for addition of protofibrils to fibers are sufficient to account for a wide variety of other observations, e.g., the effects of ionic strength or fibrinopeptide B removal or thrombospondin. The effects of lateral aggregation of fibers has also been modeled: such behavior has been observed in turbidity curves and electron micrographs of clots formed in the presence of platelet factor 4. Thus, many aspects of clot structure and factors that influence structure are directly related to the rates of these steps of polymerization, even though these effects are often not obvious. Thus, to a large extent, clot structure is kinetically determined.
This article has been cited by other articles:
 |
|
 |
|
  A. Undas, M. Kolarz, G. Kopec, and W. Tracz Altered fibrin clot properties in patients on long-term haemodialysis: relation to cardiovascular mortality Nephrol. Dial. Transplant., June 1, 2008; 23(6): 2010 - 2015. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 I. N. Chernysh and J. W. Weisel Dynamic imaging of fibrin network formation correlated with other measures of polymerization Blood, May 15, 2008; 111(10): 4854 - 4861. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 I. Parastatidis, L. Thomson, D. M. Fries, R. E. Moore, J. Tohyama, X. Fu, S. L. Hazen, H. F.G. Heijnen, M. K. Dennehy, D. C. Liebler, et al. Increased Protein Nitration Burden in the Atherosclerotic Lesions and Plasma of Apolipoprotein A-I Deficient Mice Circ. Res., August 17, 2007; 101(4): 368 - 376. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. A. Amelot, M. Tagzirt, G. Ducouret, R. L. Kuen, and B. F. Le Bonniec Platelet Factor 4 (CXCL4) Seals Blood Clots by Altering the Structure of Fibrin J. Biol. Chem., January 5, 2007; 282(1): 710 - 720. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. Park, H.-J. Doh, S.-S. A. An, J.-R. Choi, K.-H. Chung, and K.-S. Song A novel fibrinogen variant (fibrinogen Seoul II; A{alpha}Gln328Pro) characterized by impaired fibrin {alpha}-chain cross-linking Blood, September 15, 2006; 108(6): 1919 - 1924. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J.-P. Collet, J. L. Moen, Y. I. Veklich, O. V. Gorkun, S. T. Lord, G. Montalescot, and J. W. Weisel The {alpha}C domains of fibrinogen affect the structure of the fibrin clot, its physical properties, and its susceptibility to fibrinolysis Blood, December 1, 2005; 106(12): 3824 - 3830. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. A. Keller, J. Martinez, T. C. Baradet, C. Nagaswami, I. N. Chernysh, M. K. Borowski, S. Surrey, and J. W. Weisel Fibrinogen Philadelphia, a hypodysfibrinogenemia characterized by abnormal polymerization and fibrinogen hypercatabolism due to {gamma} S378P mutation Blood, April 15, 2005; 105(8): 3162 - 3168. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Vadseth, J. M. Souza, L. Thomson, A. Seagraves, C. Nagaswami, T. Scheiner, J. Torbet, G. Vilaire, J. S. Bennett, J.-C. Murciano, et al. Pro-thrombotic State Induced by Post-translational Modification of Fibrinogen by Reactive Nitrogen Species J. Biol. Chem., March 5, 2004; 279(10): 8820 - 8826. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. J. Dunn, R. A. Ariens, M. de Lange, H. Snieder, J. H. Turney, T. D. Spector, and P. J. Grant Genetics of fibrin clot structure: a twin study Blood, March 1, 2004; 103(5): 1735 - 1740. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J.P. Collet, C. Nagaswami, D.H. Farrell, G. Montalescot, and J.W. Weisel Influence of {gamma}' Fibrinogen Splice Variant on Fibrin Physical Properties and Fibrinolysis Rate Arterioscler. Thromb. Vasc. Biol., February 1, 2004; 24(2): 382 - 386. [Abstract] [Full Text]
|
|
|
|
|
|
J. L. Moen, O. V. Gorkun, J. W. Weisel, and S. T. Lord Recombinant B{beta}Arg14His fibrinogen implies participation of N-terminus of B{beta} chain in desA fibrin polymerization Blood, October 1, 2003; 102(7): 2466 - 2471. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. V. Cooper, K. F. Standeven, and R. A. S. Ariens Fibrinogen gamma-chain splice variant {gamma}' alters fibrin formation and structure Blood, July 15, 2003; 102(2): 535 - 540. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J.-P. Collet, C. Lesty, G. Montalescot, and J. W. Weisel Dynamic Changes of Fibrin Architecture during Fibrin Formation and Intrinsic Fibrinolysis of Fibrin-rich Clots J. Biol. Chem., June 6, 2003; 278(24): 21331 - 21335. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. D. Mills, R. A.S. Ariens, M. W. Mansfield, and P. J. Grant Altered Fibrin Clot Structure in the Healthy Relatives of Patients With Premature Coronary Artery Disease Circulation, October 8, 2002; 106(15): 1938 - 1942. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. F. Standeven, R. A.S. Ariens, P. Whitaker, A. E. Ashcroft, J. W. Weisel, and P. J. Grant The Effect of Dimethylbiguanide on Thrombin Activity, FXIII Activation, Fibrin Polymerization, and Fibrin Clot Formation Diabetes, January 1, 2002; 51(1): 189 - 197. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. C. Lounes, J. B. Lefkowitz, A. H. Henschen-Edman, A. I. Coates, R. R. Hantgan, and S. T. Lord The impaired polymerization of fibrinogen Longmont (B{beta}166Arg{right-arrow}Cys) is not improved by removal of disulfide-linked dimers from a mixture of dimers and cysteine-linked monomers Blood, August 1, 2001; 98(3): 661 - 666. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. MARCHI, S. LOYAU, E. ANGLES-CANO, and J. W. WEISEL Structure and Properties of Clots from Fibrinogen Bicetre II ({gamma}308 Asn->Lys): Increased Permeability due to Larger Pores, Thicker Fibers, and Decreased Rigidity Ann. N.Y. Acad. Sci., June 1, 2001; 936(1): 125 - 128. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Collen, A. Maas, T. Kooistra, F. Lupu, J. Grimbergen, F. J. L. M. Haas, D. H. Biesma, P. Koolwijk, J. Koopman, and V. W. M. van Hinsbergh Aberrant fibrin formation and cross-linking of fibrinogen Nieuwegein, a variant with a shortened A{alpha}-chain, alters endothelial capillary tube formation Blood, February 15, 2001; 97(4): 973 - 980. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Z. Yang, I. Mochalkin, and R. F. Doolittle A model of fibrin formation based on crystal structures of fibrinogen and fibrin fragments complexed with synthetic peptides PNAS, December 19, 2000; 97(26): 14156 - 14161. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. A. S. Ariens, H. Philippou, C. Nagaswami, J. W. Weisel, D. A. Lane, and P. J. Grant The factor XIII V34L polymorphism accelerates thrombin activation of factor XIII and affects cross-linked fibrin structure Blood, August 1, 2000; 96(3): 988 - 995. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. Applegate, L. S. Steben, K. M. Hertzberg, and G. Grieninger The alpha EC domain of human fibrinogen-420 is a stable and early plasmin cleavage product Blood, April 1, 2000; 95(7): 2297 - 2303. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y. Veklich, C. W. Francis, J. White, and J. W. Weisel Structural Studies of Fibrinolysis by Electron Microscopy Blood, December 15, 1998; 92(12): 4721 - 4729. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y. Veklich, E. K. Ang, L. Lorand, and J. W. Weisel The complementary aggregation sites of fibrin investigated through examination of polymers of fibrinogen with fragment E PNAS, February 17, 1998; 95(4): 1438 - 1442. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. Okumura, O. V. Gorkun, and S. T. Lord Severely Impaired Polymerization of Recombinant Fibrinogen gamma -364 Asp right-arrow His, the Substitution Discovered in a Heterozygous Individual J. Biol. Chem., November 21, 1997; 272(47): 29596 - 29601. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
O. V. Gorkun, Y. I. Veklich, J. W. Weisel, and S. T. Lord The Conversion of Fibrinogen to Fibrin: Recombinant Fibrinogen Typifies Plasma Fibrinogen Blood, June 15, 1997; 89(12): 4407 - 4414. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. L. Woodhead, C. Nagaswami, M. Matsuda, C. L. Arocha-Piñango, and J. W. Weisel The Ultrastructure of Fibrinogen Caracas II Molecules, Fibers, and Clots J. Biol. Chem., March 1, 1996; 271(9): 4946 - 4953. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. L. Mullin, O. V. Gorkun, C. G. Binnie, and S. T. Lord Recombinant Fibrinogen Studies Reveal That Thrombin Specificity Dictates Order of Fibrinopeptide Release J. Biol. Chem., August 11, 2000; 275(33): 25239 - 25246. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
